PharMerica Buys Ferrer Freeman's Stake of Amerita
Ferrer Freeman & Company, LLC (“FFC”), a healthcare focused private equity firm, today announced the sale of its interest in Amerita Inc. ("Amerita" or the "Company"), a provider of home and specialty infusion services, to PharMerica Corporation (NYSE: PMC). Terms of the transaction were not disclosed. Amerita, based in Irvine, CA, was formed in 2006 with capital from FFC and the Amerita management team. Through de novo development, acquisitions, and organic growth, the Company is now one of the nation's largest independent providers of complex pharmaceutical products and clinical services to patients outside of the hospital, with 12 branches in Colorado, Oklahoma, Tennessee, Texas and Utah. As part of the transaction, Amerita CEO Jim Glynn will go forward as the President of Amerita, a wholly owned subsidiary of PharMerica.
"FFC is very proud to have been associated with Amerita throughout its growth and development," said David Freeman, a Founding Member at FFC. "Jim Glynn and the Amerita management team have built an organization with a patient centric approach that has achieved industry leading clinical outcomes and high levels of customer service. This outstanding service record is well recognized in the communities where Amerita operates and has been the driver of the Company's impressive growth.”
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.